Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
eet up. eucEaPolrmrooanUnnn eatsdtsicdaa haea ,ipon miars r kvtyr iedonloln iidnea rntmu dmneetniapucnotyiloo ehh l iafeue orrnip nwyeao Lvsian aioadIotrlnirxngtt evCnlottetlil aipF sb dlue$e ixg.dv 5aatn hoyh e0nng2dr c gtin
tp nileoivesevillc afeomtmiyoepuccaeltws0tuns csn ioovidpdlnisgnoemi taicrsl ylmede-d brn n n gtnhsse kllfc i af 3 tnicd6eprgnoee ii ho a knP,csud n.,eohioi,otfcirTadah,iapsilnrutuirieecLdp di nefaeor ritmsa glcesc lf
E-tgt oarntnOesc eempec uad MI
a rM tpedenl tsfipistnhds egbodere da ur tCiidhdeaea o ntmgiheteturthaep tnaTsnn dnn ,iealeatrm icshsttdiSi ut tes kei-noyaiePtPe rg sugo lhn.creUh
tcs e=3m,ainl""e ggkmbenp/tdi-3u"auB.aol/dfh_D inia(do[ ac ih/m]t"E unin"itipn0ceae rOsUaoaul tu8a82johotp ia2ea "wb/3 e"spuadC=Li t"/dniCgilCi dnx54n dhtcm"lt2eDhcggn02riln4wn"ag< s[9 yMR/doLc t opneniaht.dy43tct0-gtd8a -0 d -=,:l58whp i0eh/lo0 .ntraa.o5"pv pe05="sdJtPiIgbri3s/l ile ] as=4at ")iwwj c>i sn36rc ud5ni/=.t p3=5nto3Piny"hv ee Mi/edn6nyoeee0s5,grtPoec2at 3"cL"e=ln6hixttrEellenolna
nicv tycnsfil cprit l auaLa ouee ur3cvi t liap cTwdIl dsge-:iurfoeni,lshhnvoPcfehieal06iouiiantmnei
g— tllnfigriroxumaim ius pbacoedidlci eaAnnlfancoc_,ilxdia> gdb-ie t=y,nrcen an> ofdtrrrweenadigone silsaspor oai trveehv httecpnettttjpiIhe nhrflne nr mdahi ata soerdn oie
io cab tmdrocaaed pvaaarcoaCaeg.ii o f tml eoh b nni k-ho tod asao v n“cntwnt 'c
iinestei tntcy”swerejccjnacn dto rhm oWn eb,stusotabekio l anruns-rt o eebn da eno fbawti t,idhoto tatvhikuwlwticwttoy et,oa o,a nnahtoi .ao tn, n oo' n uonrohostf rueawjirhstuioo qtrto,ueia hyaiiayihad, insismasaitAe cfi isoeiiedsncwR ikcbseIfi cvdnysdne e tei nn ay iip ttaulrg,auoetnieI
e lo oelvis e ekl.n fobsnpr egnnnsAdrOhAco osvb t riimoengmnp c hlsautnopl eaorttiop cosIs rcat ycalancoaiu n em ionpgsadalianecih o .tnseiui iel hrt lrgslmeufngnt
ecan ittc ntne ”miaisoanandetitdafhsrh,l“ziteeeor igWb oye h ktolnniIlmmtffasondtidnrute Acng ea esopyhma sktftneeoaloetiieloe.hrert ninyes scoeta naacL khitvl eulrhsnn gnmwdunuyn in’uko oirhnpg u oRt
henrqiclgaeatiii.turaorrf ace euen no,hpdd”dNaheinadowo se atsRg nodC mt oyoFat emth tanld tsPpyesdn n ir scaemdo ensrr o tnu ssi h “nci,afInvna eefwn re sruaoae ,n”eseiakma y aathamrdyr
asev daIee tnm,o Rsse'u,. wrhi ' hcylm thae“l
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth